tiprankstipranks
Trending News
More News >
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB)
NASDAQ:XTLB

XTL Biopharmaceuticals Sponsored ADR (XTLB) Revenue

Compare
104 Followers

XTL Biopharmaceuticals Sponsored ADR Revenue

XTL Biopharmaceuticals Sponsored ADR had a revenue of 162.00K in the quarter ending Sep 30, 2024, with Infinity%. This bring the company's revenue in the last twelve months to 162.00K, Decreased Infinity%. In the fiscal year ending Dec 31, 2023, XTL Biopharmaceuticals Sponsored ADR had annual revenue of 0.00 with ― growth.
Revenue (ttm)
162.00K
Revenue Growth
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
8
Market Cap
$16.39M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 20230.00
Dec 31, 20220.00
Dec 31, 20210.00
Dec 31, 20200.00
Dec 31, 20190.00
Dec 31, 20180.00
Dec 31, 20170.00
Dec 31, 20160.00
Dec 31, 20150.00
Dec 31, 20140.00-2.37M-100.00%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis